Navigation Links
Optimize Transfection of siRNAs for RNAi

By Rich Jarvis, Associate Scientist


Low transfection efficiency is the most frequent cause of unsuccessful gene silencing experiments. We have found that by optimizing cell density, transfection agent amount, and siRNA concentration, high levels of transfection efficiency can be achieved in many cell types.


Good Transfection is Critical
The ability of small interfering RNAs (siRNAs) to silence gene expression is proving to be invaluable for studying gene function in cultured mammalian cells. siRNAs can be transiently transfected into mammalian cells using commonly available transfection reagents. However, obtaining high efficiency transfection of siRNA is not trivial and may limit the utility of RNAi in some cell types.

Recent publications have described the use of cationic liposomal and polyamine based agents to facilitate delivery of siRNA into cultured mammalian cells (Byrom et al., 2002; Demeterco et al., 2002; Harborth et al., 2001). To achieve maximum effectiveness of exogenously introduced siRNAs, transfection optimization experiments are required. Failure to optimize some critical transfection parameters, such as cell culture conditions, the choice, amount, and use of transfection agents, and quantity and quality of siRNAs can render siRNA effects undetectable in tissue culture. Once an optimized protocol is developed for a particular cell type, siRNAs can be easily screened with a high degree of reproducibility.

This article summarizes optimization experiments for m
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Optimized Imaging of Protein Gels Stained with Coomassie Brilliant Blue Dye
2. Eagle Eye Optical Filter Optimized for Imaging Silver-Stained Gels
3. Optimized Dengue RT-PCR
4. Rapamycin Optimized in 100 Liter Fermentor Using BioCommand Control Strategys
5. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
6. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
7. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
8. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
9. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
10. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
11. Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection of Mammalian Cells

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Optimize Transfection siRNAs for RNAi

(Date:11/25/2009)...ArdeaBiosciences,Inc.(Nasdaq: RDEA )announcedtoday...veofficer,willpresentatthePiperJaffray21stAnnualHe...llows:,PiperJaffray21stAnnualHealthCareConference...ime,Location:TheNewYorkPalaceHotel,NewYork,NY,Webc...rget=,_blank,title=,http://www.corporate-ir.net/ir...
(Date:11/24/2009)...nt bank KTA Capital,s client Neuren Pharmaceutical...le note private placement with a U.S. institutiona...KTA Capital as Neuren,s exclusive placement agent ...PRWEB) November 23, 2009 -- The independent New Yo...ital") has announced that its client Neuren P...
(Date:11/24/2009)...Sigma-AldrichCorporation(Nasdaq: SIAL )willbeprese...at1:45PMGMTinLondon,7:45AMUS/CST.Interestedparties...ableat http://inve s tor.sig m a a ldrich.c...e. ,, AboutSigma-Aldrich: Sigma-Aldrichisale...alandbiochemicalproductsandkitsareusedinscientific...
(Date:11/24/2009)...Call/--NeurogesX,Inc.(Nasdaq: NGSX ),abiopharmaceu...ovelpainmanagementtherapies,announcedtodaythatAnth...eduledtopresentatthe21stAnnualPiperJaffrayHealthCa...alaceHotelinNewYork,NewYork. ,, Mr.DiTonnoandSt...letorespondtoquestionsduringthepresentationsandtop...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...s, Inc. (Nasdaq: EXEL ) announced today that Geor...hief executive officer will present at,the 19th An...p.m. ET /,12:00 p.m. PT on Tuesday, November 27, 2... accessed in the Event,Calendar page under Investo....com ., About Exelixis, Exelixis, Inc. is a deve...
...e,Garufi, Chairman and CEO of NicOx (Eurolist: COX...ompany,s research and development programs and the...nferences in New York,during the week of November ...lth Care Conference on November,28 at 15:00 US Eas...Time),at the Pierre New York Hotel. To access the ...
...(Nasdaq: VPHM ) today announced that Vincent Mila...ief financial officer of ViroPharma, will present,...care Conference at 3:30,P.M. ET on Tuesday, Novemb...ew York Palace Hotel., ViroPharma also announced ...e officer of ViroPharma, will present at the 19th ...
Other Biology Technology:NicOx to Present at Financial Conferences in New York on November 27, 28 and 29 2ViroPharma to Present at Two Upcoming Healthcare Conferences 2
(Date:11/24/2009)...et science is opening new doors to understanding h...the hearing of a marine mammal or if they hear it...ed X-ray scanners that NASA uses to detect flaws i...is now allowing scientists to peek inside the gian...d three-dimensional replicas of a whale,s hearing ...
(Date:11/24/2009)...atomic-level action of a remarkable class of ring-...chers with the Lawrence Berkeley National Laborato... crystallography beamline at the Advanced Light So...s in gene expression and replication, and are vita... as infectious agents, such as the human papilloma...
(Date:11/24/2009)...TON ROUGE Antarctica has long held secrets of the...il recently, there has been very little informatio...h miles of ice for millions of years. Now, a team ...SU have been funded to the tune of $10 million do...to get to the bottom of things literally. These s...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2Covidien receives FDA clearance for its Puritan Bennett 840 ventilator system 53868 1Covidien receives FDA clearance for its Puritan Bennett 840 ventilator system 53868 2Carnegie Mellons Jean VanBriesen leads research team on Monongahela River 9506 1Carnegie Mellons Jean VanBriesen leads research team on Monongahela River 9506 2Wastewater produces electricity and desalinates water 9504 1Wastewater produces electricity and desalinates water 9504 2Wastewater produces electricity and desalinates water 9504 3
... innovative new statistical method, described in t...he computation required to identify all the potent...cular physical trait, or phenotype. Thanks to the ...y, and Leonid Kruglyak, researchers have a more ef...ify all the genomic elements that produce specific...
...mbining partially differentiated stem cells with g...ion" around nerve fibers in the damaged spinal cor...h mimics the activity of two nerve growth factors,...ctrical conduction from the brain to the leg muscl... treating spinal cord injury in humans. The study ...
...nal results of a study conducted at Johns Hopkins ...y to treat heart attacks, or myocardial infarction...d from another pig,s bone marrow and injected into...n and repaired damaged heart muscle by 50 percent ...nted last fall at the 2004 Scientific Sessions of ...
Other Biology News:Improved statistical tools reveal many linked loci 2Combination therapy leads to partial recovery from spinal cord injury in rats 2Combination therapy leads to partial recovery from spinal cord injury in rats 3Stem cell therapy successfully treats heart attack in animals 2
Uniblot accessories from Sigma-Aldrich
StemSep Anti-Human CD69 Tetramer, 200 uL from StemCell Technologies, Inc.
Aquarius 384 Multichannel Pipettor from Tecan
...nx software, a multitasking application capable of...amming and operation of lab automation workcells e...tom modification by programmers. • Users cr...wchart. If you can build a flowchart, you can writ...
Biology Products: